Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Gastrointestinal - Pharmacology > Pharmacology of Acid Suppressing Drugs > Flashcards

Pharmacology of Acid Suppressing Drugs Flashcards

1
Q

What are antacids?

• what are the two general types?

A

Antacids:
• Weak Bases that can Buffer Acid

2 types:
•Absorbable and Non-Absorbable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 3 general categories of non-absorbable antacids and what are their side effects?
• what makes them non-absorbable?

A

3 Categories:
• Aluminum; AE = Constipation
• Calcium; AE = Constipation
• Magnesium; AE = Diarrhea

**These are non-absorbable because they are localized to the GI tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How do the side effects of absorbable antacids differ from those of non-absorbable antacids?
• what are the absorbable antacids?

A

Sodium Bicarbonate
• Absorbable Antacid that can leave the GI tract

AEs: Because bicarb can leave GI tract you can get systemic acid-base imbalance and sodium and H2O retention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When are antacids most appropriately used?

A

When you need FAST relief from heartburn

• Remember that these have a short duration of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the only known physiological function of H2 receptors?

A

Stimulate HCl secretion from parietal cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the source of histamine that leads to parietal cell stimulation?
• explain how histamine leads to the release of H+ from parietal cells.

A

Enterochromaffin-like cells secrete histamine (sometimes in response to Ach or Gastrin)

Histamine can bind to the H2 receptor on parietal cells and trigger the cAMP cascade

This increases activity of the H+/K+ ATPase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why do H2 blockers not lead to a complete reduction in acid production?

A

Parietal Cells can be directly acted on by Gastrin and Ach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the 4 H2RAs (H2 receptor antagonists) approved for use in the US?

A

Cimetidine
Ranitidine
Famotidine
Nizatidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

If you want an H2RA to be effective, when is the most appropriate time to administer it?
• why is this?
• What happens if you take it at a different time?
• NAME THEM

A

H2R anatagonists are most effectively used at night because they are really only good at suppressing H+ secretion in the absence of any stimuli

**If patients take them during the day or continue to eat at night after taking the drug the efficacy will be reduced and they’ll end up doing multiple doses

Cimetidine, Ranitidine, Famotidine, Nizatidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

T or F: Tolerance mechanisms can develop against H2RAs

A

True, H2RAs are antagonists so the cell can respond by upregulating the receptors or modifying other aspects of the cAMP cascade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

T or F: H2RAs are your first choice in the treatment of non-H. Pylori related Peptic Ulcer Disease
• name the H2RAs

A

False, they used to be but now PPIs are the standard of tx in these cases

Cimetidine, Ranitidine, Famotidine, Nizatidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why are H2RAs inferior to PPIs in their acid blocking capacity?

A

They are less effective than PPIs for GERD because they do not elevate intragastric pH sufficiently and do not counteract food stimulated secretion

They lower gastric acid secretion by 90% (pH 1-2 to pH 2-3) but at this pH PEPSINOGEN is still active and can still damage the esophagus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the possible Drug interactions with H2RAs?

• Name them all.

A

Cimetidine inhibits P450’s and can therefore have pretty severe enhancement of effects on drugs like:
• Pheytoin
• Warfarin
• Theophylline

Other H2RAs (Ranitidine, Famotidine, Nizatidine) do not have this problem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What type of patient is most effectively treated with an H2RA?
• how do they compare to antacids?

A

Someone with mild GERD and relatively infrequent Symptoms

H2RAs have slower onset of action when compared to antacids but have a longer duration of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Name the PPIs.

A

the “Prazoles”

Omeprazole
Lansoprazole
Rabeprazole
Pantoprazole 
Esomeprazole
IR-OME/NaHCO3
Dexlansoprazole
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the purified enantiomers of omeprazole and Lansoprazole?
• are they R or S?

A

Omeprazole is purified to its S enantiomer Esomeprasole

Lansoprazole is purified to its R enantiomer Dexlansoprazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Which PPIs are enterically coated?
• which are not?
• Why is enteric coating necessary?

A

All except Immediate Release - Omeprazole (IR-OME)/NaHCO3 are give as enteric coated capsules

This is necessary because PPIs are ACID LABILE

18
Q

What are PPIs that are not IR-OME referred to?

A

These are Delayed Release

19
Q

Describe the ADME of PPIs.
• how often do they need to be administered?
• How long can levels be detected in blood?

A

PPIs are absorbed after enteric coating is degraded

PPIs gets absorbed into the blood and concentrated in parietal cells

Metabolism occurs via CYP2C19 and CYP3A4 and then the drugs excreted in kidney

Metabolism leads to elimination of the drug from the blood in 1-2 hours but CONCENTRATION IN PARIETAL CELLS means the EFFECTS PERSIST LONG ENOUGH FOR ONCE-A-DAY DOSING

20
Q

Do doses of PPI need to be adjusted for renal or Hepatic impairment?

A

Renal:
• NO - because most biotransformation is hepatic

Hepatic:
• In moderate hepatic dysfunction the dose should be lowered

***Remember PPIs are the “prazoles”

21
Q

PPIs - the “-Prazoles”

MOA

A

MOA of PPIs
• PPIs are taken up by parietal cells and get PROTONATED

  • Excreted on luminal aspect to become SULFENAMIDES
  • -SH bond with CYSTEINE on H/K ATPases
  • THIS KNOCKS OUT THE FUNCTION OF THE PUMP AND ACID SECRETING CAPACITY IS ONLY RESTORED BY GENERATION OF A NEW PUMP
22
Q

T or F: PPIs completely abolish acid secretion

A

False, they reduce it a lot, but do not completely eliminate it - gastric pH is often below 3 for a fews hour of the day while on these

23
Q

If PPIs do not completely abolish acid secretion, then how are they so effective?
• does resistance to PPIs develop?

A

PPIs raise the gastric pH above 4 for a significant fraction of the day
• This is important because PEPSIN CANNOT BE ACTIVATED AT A pH ABOVE 4
• This allows time for healing of the gastric mucosa

**Resistance does not develop to PPIs (they are not competitive antagonists like H2RAs)

24
Q

T or F: patients who abruptly stop taking PPIs may experience abrupt rebound hypersecretion of acid

A

True, this effect is mainly the case in patients that are H. Pylori negative (and therefore their gastric disease was caused by hypersecretion of acid)

25
Q

PPIs

• Potential Adverse Effects

A
  • Headache, Diarrhea, Skin Rash, Abdominal Pain
  • Increased risk for Bacterial infections (C. Diff) - due to lack of stomach acidity
  • Possible increased risk of BONE fractures
26
Q

PPIs

• what potential vitamin deficiency theoretically could develop?

A

Vitamin B12 extraction is somewhat dependent on gastric acid. Reduced gastric acid could cause Macrosidic anemia

**Monitoring of B12 is not necessary in these patients

27
Q

PPIs

• when is optimal dosing?

A

PPIs should ideally be given in the morning on an empty stomach around 30-60 minutes BEFORE food

• This timing gives adequate time for the PPI to get into the bloodstream, upon EATING 30-60 minutes later PARIETAL CELLS will uptake a lot of PPI

Note: twice daily dosing is not usually necessary, but if it is implemented it should be given BEFORE dinner. (2x per day is not FDA approved)

28
Q

What is the relative effectiveness of PPIs when compared to H2RAs when it comes to healing Duodenal and Gastric ulcers?

A

PPIs heal 2x as fast

29
Q

How do healing rates of PPI healing compare to H2RA healing in the treatment of GERD and non-erosive esophagitis?

A

PPIs are better than H2RAs in BOTH GERD and NERD

30
Q

PPI
• Drug interactions
• Which of the PPIs has the most?

A

OMEPRAZOLE has the most drug interactions of all the PPIs

PPI potential drug interactions are related to metabolism mediated by CYP3A4 and CYP2C19

Significant interactions with OMEPRAZOLE include:
•Warfarin
• Pheytoin
• Diazepam (essentially inconsequential)
• CLOPIDOGREL

31
Q

PPIs
• Explain the potential interactions between Clopidogrel and PPIs
• which PPIs is this effect significant with?
• Which PPIs is this effect NOT significant with?

A

Clopidogrel
• is given as a PROdrug and must be activated by CYP2C19 that is INHIBITED by omeprazole and esomeprazole in vitro

• This could cause pts. on clopidogrel to return to procoagulant state

SAFE PPIs to Use with Clopidogrel:
• Lansoprazole
• Pantoprazole
• Dexlansoprazole

32
Q

What is the MOA of Clopidogrel?

A

clopidogrel prevents binding of adenosine diphosphate (ADP) to its platelet receptor, impairing the ADP-mediated activation of the glycoprotein GPIIb/IIIa complex.

glycoprotein GPIIb/IIIa complex is the major receptor for fibrinogen, its impaired activation prevents fibrinogen binding to platelets and inhibits platelet aggregation

33
Q

A patient is on Clopidogrel and needs to go on a PPI, which can you give them?

A

SAFE PPIs to Use with Clopidogrel:
• Lansoprazole
• Pantoprazole
• Dexlansoprazole

34
Q

What are the mains indication for PPI treatment?

A
  • GERD - heals and prevents
  • NSAID/Asprin associated ulcers - prevents rebleeding once NSAID/Asprin therapy is restarted
  • Prevention of Ulcer rebleeding
35
Q

T or F: all patients with a history of peptic ulcer disease must be tested for an H. Pylori infection

A

True

36
Q

What are the two most commonly used treatments for H. pylori infections?

A
  1. Clarithromycin-based triple therapy
    • PPI + Clarithromycin + Amoxicillin
    • PPI + Clarithromycin + Metronidazole (if patient is penicillin allergic)
  2. Bismuth-based Quadruple Therapy
    • PPI (or H2RA) + Bismuth + Metronidazole + Tetracycline

NO SUBSTITUTIONS ALLOWED

37
Q

T or F: PPI monotherapy is effective in treating H. pylori.

A

False, but they DO IMPROVE THE EFFICACY OF THE ANTIBIOTICS

38
Q

How effective are Clarithromycin triple therapy and Bismuth quadruple therapy in clearing H. pylori infections?

A

only 70-75% effective

39
Q

Why are failure rates high in the treatment of H. pylori associated infections?

A
  • Antimicrobial Resistance
  • Poor Compliance
  • Both
40
Q

T or F: If a patient fails triple therapy, you should prescribe it again and explain the importance of medication compliance.

A

FALSE, if a patient fails Clarithromycin triple therapy (PPI + Clarithromycin + Amoxicillin/Metronidazole) its because the bacteria is CLARITHROMYCIN RESISTANT

41
Q

What should you do if a patient fails Triple therapy?

A

DO NOT represcribe clarithromycin

•Metronidazole is probably okay to represcribe (emergence of resistance is low)

  • NO RESISTANCE TO AMOXICILLIN OR TETRACYCLINE SO THESE CAN BE ADDED TO NEW REGIMENS AS NEED

Gastrointestinal - Pharmacology (2 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions